DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma

We studied the feasibility, efficacy, and mechanisms of dendritic cell (DC) immunotherapy against murine malignant glioma in the experimental GL261 intracranial (IC) tumor model. When administered prophylactically, mature DCs (DCm) ex vivo loaded with GL261 RNA (DCm-GL261-RNA) protected half of the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Maes, Wim, Rosas, Georgina Galicia, Verbinnen, Bert, Boon, Louis, De Vleeschouwer, Steven, Ceuppens, Jan L., Van Gool, Stefaan W.
Format: Artigo
Idioma:Inglês
Publicat: Duke University Press 2009
Matèries:
Basic and Translational Investigations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765342/
https://ncbi.nlm.nih.gov/pubmed/19336528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2009-004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars